Costco Wholesale's profit fell 15 percent, missing estimates, hurt by weaker gross margins in its fresh-food business and some non-foods merchandises.» Read More
CNBC's Brian Sullivan reports today's sunshine stock, Alexion Pharmaceuticals hit an all time high today.
The drug developer's stock took a hit Thursday, after data was released linking an ingredient in its weight loss treatment to an increased risk of birth defects.
Accused of running a $7B ponzi scheme, Allen Stanford was in court today and CNBC's Scott Cohn has the story.
The "Mad Money" host reveals what earnings and other event he plans to monitor.
CNBC's Courtney Reagan reports on lifted holiday retail sales at drug stores.
A breakdown of better-than-expected earnings from the generic drug maker, with Joseph Papa, Perrigo CEO.
Joseph Papa sits down with Cramer and explains why things are looking good for the private label drug maker.
Are pharmacy benefit managers becoming obsolete? CNBC's Herb Greenberg says consumers can now buy away from their PBM and insurance plans at Costco, Walmart, Target, and Walgreens.
Mad Money host Jim Cramer says every portfolio should have some defensive, recession-resistant stocks, with Greg Wasson, Walgreens CEO.
Discussing higher drug prices and supply shortages in the pharmaceutical industry with Heather Bresch, Mylan Inc. CEO, who says her company is hiring and would hire more if her American manufacturing jobs were given a level playing field.
"We have had a lot of volatility on the retail sales data because of the Royal Wedding and the number of public holidays. The June data was quite positive, so I think a small increase again in July is an encouraging sign," Stephane Deo, head of european economic research at UBS, told CNBC.
Ahead of its earnings report in mid-August, the retailer has announced plans to add 6,300 employees. Some early birds have jumped in to buy more than 6,000 August 50 calls for $1.63.
Reinventing the neighborhood drugstore into a twenty-two thousand square foot superstore, which includes an on-site doctor, with Joe Magnacca, Duane Reade president.
Blu, the maker of electronic cigarettes that release a nicotine-laden vapor instead of smoke, has developed packs of e-cigarettes with sensors that will let users know when other e-smokers are nearby, the New York Times reports.
Cramer explains when it's never a good idea to abandon turbo-charged growth stocks.
The drug industry stands to lose billions of dollars a year, as patents to their key drugs expire, with David Brennan, Astrazeneca CEO.
CNBC's Darren Rovell has an update on GNC's IPO pricing.
Why the "Fast Money" traders are monitoring these market moving stocks.
Don't get lost on the highways of investing. Here's how Cramer plans to navigate the days to come.